About Us
Success Stories
Articles
FAQ
Contact Us

Our Services
Our Locations
Rescue Studies
Accell Oncology

Select Page

Accell Oncology Business Development Unit at ASCO Annual Meeting 2022

by bd@accellclinical.com | Jun 22, 2022 | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Search for:

Recent Posts

Hello world!

Recent Comments

Archives

December 2017

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Company News

April 3, 2023

Accell has launched new challenging projects

Accell’s team is enthusiastic to announce that it is about to start two new Phase III studies in oncology and ophthalmology.

February 6, 2023

European Union Clinical Trial Regulation 2023 update

The EU has finally implemented its single portal submission regulation for clinical trial authorization. Accell is ready for the change. Are you?

Events

CPHI Frankfurt 2022

Meet Accell’s team at the biggest pharma industry event of 2022 – CPHI Frankfurt, held at Messe Frankfurt, Frankfurt, Germany on November 1-3, 2022.

2022 ASCO Annual Meeting

Learn numerous advantages of running an oncology clinical trial in Eastern Europe from Accell’s team, your trusted CRO partner.

Immuno-Oncology 360°

On February 26-28, 2020 Natalia Nayanova, Accell’s Founder and Managing Member, attended the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square in New York City.

Accell Clinical Research, LLC is an International Contract Research Organization (CRO) supporting innovation with superior clinical trial services in Europe and the Eurasian Economic Union for over a decade.

Facebook


Careers
Privacy Notice
Site Map

X

We are here when you need us.
Get in touch and let’s start something great together.

First Name *

Company Name *

Last Name *

Your E-mail *

What Is Your Indication?

Tell Us Your Phase

* required fields

Sign Up for Accell’s Newsletter